About BioCopy
BioCopy is a company based in Basel (Switzerland) founded in 2018 by Niko Bausch and Gunter Roth.. BioCopy offers products and services including Drug Discovery Platform, Antibody Engineering, and Precision Screening. BioCopy operates in a competitive market with competitors including BeiGene, Moderna, Incyte, ALX Oncology and MorphoSys, among others.
- Headquarter Basel, Switzerland
- Founders Niko Bausch, Gunter Roth
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biocopy Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$58.01 K (USD), Grant
Sep 30, 2018
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCopy
BioCopy offers a comprehensive portfolio of products and services, including Drug Discovery Platform, Antibody Engineering, and Precision Screening. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-based system for matching biotherapeutics to cancer cells.
Automated platform for developing next-generation biotherapeutics.
Tool for speeding up risk assessment in drug discovery.
Funding Insights of BioCopy
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $58,006
-
First Round
First Round
(01 Jun 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2018 | Amount | Grant - BioCopy | Valuation |
investors |
|
| Jun, 2018 | Amount | Grant - BioCopy | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioCopy
BioCopy has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioCopy
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioCopy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocopy Comparisons
Competitors of BioCopy
BioCopy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Incyte, ALX Oncology and MorphoSys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
ALX Oncology is focused on advancing cancer treatment therapies.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
mRNA therapeutics platform is provided for multi-functional treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biocopy
Frequently Asked Questions about BioCopy
When was BioCopy founded?
BioCopy was founded in 2018.
Where is BioCopy located?
BioCopy is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Who is the current CEO of BioCopy?
Gunter Roth is the current CEO of BioCopy. They have also founded this company.
What does BioCopy do?
BioCopy was founded in 2018 in Basel, Switzerland, within the biotechnology sector. Immunotherapies targeting tumors and autoimmune diseases are developed through drug discovery processes. State-of-the-art microarray technology is employed to expedite immunoprofiling and the screening of T-cell receptors against various antigen-HLA complexes. Operations focus on immuno-oncological therapeutics to address unmet needs in oncology and autoimmunity.
Who are the top competitors of BioCopy?
BioCopy's top competitors include Moderna, BeiGene and Strand Therapeutics.
What products or services does BioCopy offer?
BioCopy offers Drug Discovery Platform, Antibody Engineering, and Precision Screening.
Who are BioCopy's investors?
BioCopy has 2 investors. Key investors include European Union, and EIC Fund.